Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

6 hours ago 2

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark’s stock tumbled.